Under the terms of the settlement, eTrials has entered into a non-exclusive licensing arrangement and agreed to pay Datasci $1.75 million as an upfront license fee for its legacy EDC products ASFlash, QSCapture and WebCapture. In return, Datasci has agreed to dismiss its claims with prejudice and acknowledge that eTrials’s current EDC 2 product is not subject to any future royalty obligations.
Chip Jennings, president and CEO of eTrials Worldwide, said: “The settlement limits any future exposure and allows us to focus all of our attention on improving eTrials’s core operations and expanding our market share within the rapidly growing market for eClinical technologies and services.”